Navigation Links
Number of Matches Played Determines Teen Tennis Players' Risk for Medical Withdrawal
Date:4/28/2009

The number of matches junior tennis players compete in during a tournament directly affects their risk for medical withdrawal during a tournament concluded a study published in the youth focused May/June 2009 issue of Sports Health: A Multidisciplinary Approach.

Rosemont, IL (Vocus) April 28, 2009 -- The number of matches junior tennis players compete in during a tournament directly affects their risk for medical withdrawal during a tournament concluded a study published in the youth focused May/June 2009 issue of Sports Health: A Multidisciplinary Approach. The study, which analyzed data for every match competed at all four 2005 United States Tennis Association (USTA) junior national tennis tournaments, discovered that the risk a player might withdrawal from the tournament due to a injury or illness increased significantly after their fourth match.

"It makes sense that a player would have an increased risk for injury or illness as the tournament continues due to variables such as dehydration, stress (both emotional and physical), and exhaustion," explains lead author Neeru A. Jayanthi, MD, from Loyola University Chicago, "until this point, however, there have been no large-scale studies designed to determine the specific risk factors related to medical withdrawals. This study moves us past that; we now have data to support what was before an intuitive guess."

Medical withdrawal, which is self-reported can occur prior to or during a match and is defined as an injury or illness that prohibits the athlete from continuing to compete. Competitive junior tennis players not only have the opportunity to participate in local and sectional tournaments but also between 48-64 national level tournaments per year. A
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Some Reports Put Number of U.S. Swine Flu Cases at 50
2. Study links arm/hand swelling to number of lymph nodes removed during breast cancer surgery
3. WellSpring Pharmaceutical Corp. Emetrol(R) Consumer Brand Achieves Number One Position in Anti-Nausea Category
4. Number of People Affected By Climate Disaster Up 54% By 2015
5. Physicians "Get Smart" - Number of Docs Using Smartphones Surges to 64% in 2009
6. Record Number of Volunteers Provided Free Dental Care to Needy Children in Minnesota
7. A New Number Everyone Should Know: Their PDQ
8. Number of Revascularization Procedures, Related In-Hospital Mortality and Some Complications Decline, While Rates of Infection and Acute Respiratory Distress Syndrome (ARDS) Following Coronary Artery Bypass Graft (CABG) Surgery Increase
9. As the Number of Unemployed Grows, Pfizer Helpful Answers and SABEResPODER Join Forces to Educate Hispanics Who Lack Health Insurance About How to Access Prescription Medicines
10. Video: Astrazeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nations Number One Killer
11. Record number of patients seek laser treatments to take lightyears off their faces
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Number of Matches Played Determines Teen Tennis Players' Risk for Medical Withdrawal 
(Date:5/29/2015)... May 29, 2015 This is ... state of the Naproxen industry.The report provides a ... applications and industry chain structure. The Naproxen ... markets including development trends, competitive landscape analysis, and ... discussed as well as manufacturing processes and cost ...
(Date:5/29/2015)... 2015 The FSH Society ... science of the little-known and incurable disease, facioscapulohumeral ... the second FSHD Trial Preparedness Workshop. The Workshop, ... University of Rochester Medical Center in Rochester, New ... around the world, including representatives from industry, the ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 ... H1 2015” provides comprehensive information on the ... strengthens R&D pipelines by identifying new targets ... products. Complete report on H1 2015 pipeline ... data tables and 13 figures, spread across ...
(Date:5/29/2015)... For the third year, Nike Ultimate Camps will ... ultimate community an opportunity to experience ultimate training techniques in ... of the USAU Nike Ultimate Camp is to provide a ... character, and make lifelong friends. , The USAU Nike Ultimate ... skill and ability levels, ages 10-18. Camp will run from ...
(Date:5/29/2015)... 2015 A multi-center study led ... a urine test can determine if a patient ... Dr. James McKiernan presented these findings at the ... , Dr. McKiernan is the urologist-in-chief at ... chair of the Department of Urology at Columbia ...
Breaking Medicine News(10 mins):Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 3Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:US Sports Camps, Nike Sports Camps, and USA Ultimate Host Third Summer of Ultimate Camp in Denver 2Health News:Urine Test Detects Prostate Cancer with 92 Percent Accuracy, According to Study 2Health News:Urine Test Detects Prostate Cancer with 92 Percent Accuracy, According to Study 3
... YORK, Aug. 27 Dr. Steven Victor, CEO of Las ... announce the airing of their infomercial promoting laser assisted liposuction. This is ... , , The laser makes the procedure of ... can virtually go back to work the next day with very little bruising ...
... , , , PHOENIX, Aug. 27 ... family members to serve as caregivers for older adults. Caregiving can be ... amazing gift to allow a loved one to "age in place" rather ... Medicare Advantage Plan, offers these seven secrets to success for caregivers of ...
... , , , ... has been named this year,s honorary chair for the Los Angeles Jewish ... one of the largest and most popular walks to take place each ... Sunday, December 6, in Reseda. , , ...
... Lifetime of Achievement Traces Arc of American Dream , , ... in New York City ... venture capitalist and philanthropist, will be Grand Marshal of the 2009 Columbus Day Parade in ... of Home Depot and chairman of the NYU Langone Medical Center, will lead contingents of ...
... SHANGHAI, Aug. 27 /PRNewswire-Asia/ -- Linkwell Corporation (OTC Bulletin,Board: ... in China, announced that its 90% held,subsidiary, Shanghai Likang ... of Likang -- The Establishment of One Hundred Model,Hospitals, ... to September,2010. , The COO ...
... , Former President Will Address Issues ... Aug. 27 Chicago House & Social Service Agency, the first organization ... HIV and AIDS, will host their first ever Speaker Series Luncheon on ... , The luncheon will feature a speech from President ...
Cached Medicine News:Health News:Seven Secrets to Successful Caregiving of Older Adults 2Health News:Award-Winning Actress and Director Anjelica Huston Selected as Honorary Chair for L.A. Jewish Home's 'Walk of Ages X' 2Health News:Award-Winning Actress and Director Anjelica Huston Selected as Honorary Chair for L.A. Jewish Home's 'Walk of Ages X' 3Health News:Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal 2Health News:Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal 3Health News:Kenneth G. Langone, Home Depot Co-Founder, Chairman of the NYU Langone Medical Center, to Lead 65th Annual Columbus Day Parade as Grand Marshal 4Health News:Linkwell Corporation Announces Launch of the 'Establishment of 100 Model Hospitals' Across China 2Health News:Linkwell Corporation Announces Launch of the 'Establishment of 100 Model Hospitals' Across China 3Health News:President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon 2
(Date:5/29/2015)... , May 29, 2015  Eli Lilly and ... AZN ) today announced that they have entered into ... preliminary efficacy of AstraZeneca,s investigational anti-PD-L1 immune checkpoint inhibitor, ... VEGF Receptor 2 antiangiogenic cancer medicine. The planned study ... with advanced solid tumors. The Phase I ...
(Date:5/29/2015)... , May 29, 2015 Educating ... of the Association for the Advancement of Wound ... With support from AAWC,s corporate partners, the ... Portal on the AAWC website at ... wound care pathway with links to various CME/CEU ...
(Date:5/28/2015)... HOUSTON , May 28, 2015 /PRNewswire/ - ESSA ... financial results for the second quarter and three and six ... expressed in Canadian dollars and in accordance with International Financial ... ESSA recorded a net loss of $5.9 million ($0.35 ... 2015 (Q2-2015), compared to a net loss of $0.4 million ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14The Association for the Advancement of Wound Care Educates the Public 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... Presented at the 132nd Annual Meeting of the American Neurological ... Association in ... presented results from two,Phase III pivotal trials and one open-label ... restless legs,syndrome (RLS). These rotigotine data showed significant drops in ...
... Boehringer Ingelheim,Pharmaceuticals, Inc. today announced that ... full (traditional) approval of Aptivus(R),(tipranavir) capsules. The ... 2005; accelerated approval is a regulatory process ... or life-threatening illnesses. The full,approval of APTIVUS ...
Cached Medicine Technology:Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome 2Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome 3Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome 4Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome 5Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 2Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 3Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 4Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 5Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 6Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 7Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA 8
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: